Pain and depression comorbidity: A preclinical perspective

Behavioural Brain Research

Volumn 276, Issue , 2015, Pages 92-98

  Li, Jun Xu ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Animal model; Comorbidity; Depression; Domain interplay; Pain

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; INDOLEAMINE 2,3 DIOXYGENASE;

BRAIN REGION; CAUSAL ATTRIBUTION; CELL PROLIFERATION; COMORBIDITY; DEPRESSION; DISEASE EXACERBATION; DISEASE PREDISPOSITION; ENZYME METABOLISM; GENE; GENE EXPRESSION; HUMAN; HYPERALGESIA; IL 10 GENE; IL 1BETA GENE; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PAIN; PAIN ASSESSMENT; PAIN THRESHOLD; PHENOTYPE; PREVALENCE; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVIEW; SOCIAL INTERACTION; STIMULUS RESPONSE; ANIMAL; COMPLICATION; DISEASE MODEL; PATHOPHYSIOLOGY; PSYCHOLOGY;

ANIMALS; DEPRESSION; DISEASE MODELS, ANIMAL; HUMANS; PAIN;

EID: 84908572038     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2014.04.042     Document Type: Review

References (89)

1. Schappert S.M., Nelson C. National Ambulatory Medical Care Survey: 1995-96 summary. Vital Health Stat 1999, 13(i-vi):1-122.
2. Blyth F.M., March L.M., Brnabic A.J., Jorm L.R., Williamson M., Cousins M.J. Chronic pain in Australia: a prevalence study. Pain 2001, 89:127-134.
3. Currie S.R., Wang J. Chronic back pain and major depression in the general Canadian population. Pain 2004, 107:54-60.
4. Institute of Medicine Relieving pain in America: a blueprint for transforming prevention, care, education, and research 2011, The National Academies Press, Washington, DC.
5. Kessler R.C., Birnbaum H., Bromet E., Hwang I., Sampson N., Shahly V. Age differences in major depression: results from the National Comorbidity Survey Replication (NCS-R). Psychol Med 2010, 40:225-237.
6. Monroe S.M., Harkness K.L. Recurrence in major depression: a conceptual analysis. Psychol Rev 2011, 118:655-674.
7. Yiend J., Paykel E., Merritt R., Lester K., Doll H., Burns T. Long term outcome of primary care depression. J Affect Disord 2009, 118:79-86.
8. Alexopoulos G.S. Depression in the elderly. Lancet 2005, 365:1961-1970.
9. Andrews G., Issakidis C., Sanderson K., Corry J., Lapsley H. Utilising survey data to inform public policy: comparison of the cost-effectiveness of treatment of ten mental disorders. Br J Psychiatry 2004, 184:526-533.
10. Rush A.J. Limitations in efficacy of antidepressant monotherapy. J Clin Psychiatry 2007, 68(Suppl. 10):8-10.
11. Greenberg P.E., Kessler R.C., Birnbaum H.G., Leong S.A., Lowe S.W., Berglund P.A., et al. The economic burden of depression in the United States: how did it change between 1990 and 2000. J Clin Psychiatry 2003, 64:1465-1475.
12. Sobocki P., Jonsson B., Angst J., Rehnberg C. Cost of depression in Europe. J Ment Health Policy Econ 2006, 9:87-98.
13. Gallagher R.M., Verma S. Managing pain and comorbid depression: a public health challenge. Semin Clin Neuropsychiatry 1999, 4:203-220.
14. Blier P., Abbott F.V. Putative mechanisms of action of antidepressant drugs in affective and anxiety disorders and pain. J Psychiatry Neurosci 2001, 26:37-43.
15. Campbell L.C., Clauw D.J., Keefe F.J. Persistent pain and depression: a biopsychosocial perspective. Biol Psychiatry 2003, 54:399-409.
16. Nicolson S.E., Caplan J.P., Williams D.E., Stern T.A. Comorbid pain, depression, and anxiety: multifaceted pathology allows for multifaceted treatment. Harv Rev Psychiatry 2009, 17:407-420.
17. Chopra K., Arora V. An intricate relationship between pain and depression: clinical correlates, coactivation factors and therapeutic targets. Expert Opin Ther Targets 2014, 18:159-176.
18. Bair M.J., Robinson R.L., Katon W., Kroenke K. Depression and pain comorbidity: a literature review. Arch Intern Med 2003, 163:2433-2445.
19. Liu M.G., Chen J. Preclinical research on pain comorbidity with affective disorders and cognitive deficits: challenges and perspectives. Prog Neurobiol 2014.
20. Leino P., Magni G. Depressive and distress symptoms as predictors of low back pain, neck-shoulder pain, and other musculoskeletal morbidity: a 10-year follow-up of metal industry employees. Pain 1993, 53:89-94.
21. Mathew R.J., Weinman M.L., Mirabi M. Physical symptoms of depression. Br J Psychiatry 1981, 139:293-296.
22. Kroenke K., Spitzer R.L., Williams J.B., Linzer M., Hahn S.R., deGruy F.V., et al. Physical symptoms in primary care, predictors of psychiatric disorders and functional impairment. Arch Fam Med 1994, 3:774-779.
23. Croft P.R., Papageorgiou A.C., Ferry S., Thomas E., Jayson M.I., Silman A.J. Psychologic distress and low back pain. Evidence from a prospective study in the general population. Spine (Phila Pa 1976) 1995, 20:2731-2737.
24. Von Korff M., Dworkin S.F., Le Resche L., Kruger A. An epidemiologic comparison of pain complaints. Pain 1988, 32:173-183.
25. Magni G., Marchetti M., Moreschi C., Merskey H., Luchini S.R. Chronic musculoskeletal pain and depressive symptoms in the National Health and Nutrition Examination. I. Epidemiologic follow-up study. Pain 1993, 53:163-168.
26. Dworkin R.H., Gitlin M.J. Clinical aspects of depression in chronic pain patients. Clin J Pain 1991, 7:79-94.
27. Taloyan M., Lofvander M. Depression and gender differences among younger immigrant patients on sick leave due to chronic back pain: a primary care study. Prim Health Care Res Dev 2014, 15:5-14.
28. Kroenke K., Wu J., Bair M.J., Krebs E.E., Damush T.M., Tu W. Reciprocal relationship between pain and depression: a 12-month longitudinal analysis in primary care. J Pain 2011, 12:964-973.
29. Mutschler I., Ball T., Wankerl J., Strigo I.A. Pain and emotion in the insular cortex: evidence for functional reorganization in major depression. Neurosci Lett 2012, 520:204-209.
30. Apkarian A.V., Hashmi J.A., Baliki M.N. Pain and the brain: specificity and plasticity of the brain in clinical chronic pain. Pain 2011, 152:S49-S64.
31. Gormsen L., Ribe A.R., Raun P., Rosenberg R., Videbech P., Vestergaard P., et al. Pain thresholds during and after treatment of severe depression with electroconvulsive therapy. Eur J Pain 2004, 8:487-493.
32. Paoli F., Darcourt G.P.C. Note préliminaire sur l'action de l'imipramine dan les états doloreux. Rev Neurol 1960, 2:503-504.
33. Max M.B., Schafer S.C., Culnane M., Smoller B., Dubner R., Gracely R.H. Amitriptyline, but not lorazepam, relieves postherpetic neuralgia. Neurology 1988, 38:1427-1432.
34. Watson C.P., Evans R.J., Reed K., Merskey H., Goldsmith L., Warsh J. Amitriptyline versus placebo in postherpetic neuralgia. Neurology 1982, 32:671-673.
35. Alcoff J., Jones E., Rust P., Newman R. Controlled trial of imipramine for chronic low back pain. J Fam Pract 1982, 14:841-846.
36. Mogil J.S. Animal models of pain: progress and challenges. Nat Rev Neurosci 2009, 10:283-294.
37. Le Bars D., Gozariu M., Cadden S.W. Animal models of nociception. Pharmacol Rev 2001, 53:597-652.
38. Li J.X. The application of conditioning paradigms in the measurement of pain. Eur J Pharmacol 2013, 716:158-168.
39. Xu Y., Barish P.A., Pan J., Ogle W.O., O'Donnell J.M. Animal models of depression and neuroplasticity: assessing drug action in relation to behavior and neurogenesis. Methods Mol Biol 2012, 829:103-124.
40. Krishnan V., Nestler E.J. Animal models of depression: molecular perspectives. Curr Top Behav Neurosci 2011, 7:121-147.
41. Suzuki T., Amata M., Sakaue G., Nishimura S., Inoue T., Shibata M., et al. Experimental neuropathy in mice is associated with delayed behavioral changes related to anxiety and depression. Anesth Analg 2007, 104:1570-1577. [table of contents].
42. Gai B.M., Bortolatto C.F., Bruning C.A., Zborowski V.A., Stein A.L., Zeni G., et al. Depression-related behavior and mechanical allodynia are blocked by 3-(4-fluorophenylselenyl)-2,5-diphenylselenophene in a mouse model of neuropathic pain induced by partial sciatic nerve ligation. Neuropharmacology 2014, 79:580-589.
43. Fukuhara K., Ishikawa K., Yasuda S., Kishishita Y., Kim H.K., Kakeda T., et al. Intracerebroventricular 4-methylcatechol (4-MC) ameliorates chronic pain associated with depression-like behavior via induction of brain-derived neurotrophic factor (BDNF). Cell Mol Neurobiol 2012, 32:971-977.
44. Hu B., Doods H., Treede R.D., Ceci A. Depression-like behaviour in rats with mononeuropathy is reduced by the CB2-selective agonist GW405833. Pain 2009, 143:206-212.
45. Jesse C.R., Wilhelm E.A., Nogueira C.W. Depression-like behavior and mechanical allodynia are reduced by bis selenide treatment in mice with chronic constriction injury: a comparison with fluoxetine, amitriptyline, and bupropion. Psychopharmacology (Berl) 2010, 212:513-522.
46. Zhao X., Wang C., Zhang J.F., Liu L., Liu A.M., Ma Q., et al. Chronic curcumin treatment normalizes depression-like behaviors in mice with mononeuropathy: involvement of supraspinal serotonergic system and GABA receptor. Psychopharmacology (Berl) 2013.
47. Goffer Y., Xu D., Eberle S.E., D'Amour J., Lee M., Tukey D., et al. Calcium-permeable AMPA receptors in the nucleus accumbens regulate depression-like behaviors in the chronic neuropathic pain state. J Neurosci 2013, 33:19034-19044.
48. Wang J., Goffer Y., Xu D., Tukey D.S., Shamir D.B., Eberle S.E., et al. A single subanesthetic dose of ketamine relieves depression-like behaviors induced by neuropathic pain in rats. Anesthesiology 2011, 115:812-821.
49. Goncalves L., Silva R., Pinto-Ribeiro F., Pego J.M., Bessa J.M., Pertovaara A., et al. Neuropathic pain is associated with depressive behaviour and induces neuroplasticity in the amygdala of the rat. Exp Neurol 2008, 213:48-56.
50. Norman G.J., Karelina K., Zhang N., Walton J.C., Morris J.S., Devries A.C. Stress and IL-1beta contribute to the development of depressive-like behavior following peripheral nerve injury. Mol Psychiatry 2010, 15:404-414.
51. Norman G.J., Karelina K., Morris J.S., Zhang N., Cochran M., Courtney DeVries A. Social interaction prevents the development of depressive-like behavior post nerve injury in mice: a potential role for oxytocin. Psychosom Med 2010, 72:519-526.
52. Hasnie F.S., Wallace V.C., Hefner K., Holmes A., Rice A.S. Mechanical and cold hypersensitivity in nerve-injured C57BL/6J mice is not associated with fear-avoidance- and depression-related behaviour. Br J Anaesth 2007, 98:816-822.
53. Kontinen V.K., Kauppila T., Paananen S., Pertovaara A., Kalso E. Behavioural measures of depression and anxiety in rats with spinal nerve ligation-induced neuropathy. Pain 1999, 80:341-346.
54. Yalcin I., Bohren Y., Waltisperger E., Sage-Ciocca D., Yin J.C., Freund-Mercier M.J., et al. A time-dependent history of mood disorders in a murine model of neuropathic pain. Biol Psychiatry 2011, 70:946-953.
55. Kim H., Chen L., Lim G., Sung B., Wang S., McCabe M.F., et al. Brain indoleamine 2,3-dioxygenase contributes to the comorbidity of pain and depression. J Clin Invest 2012, 122:2940-2954.
56. Tosic-Golubovic S., Miljkovic S., Nagorni A., Lazarevic D., Nikolic G. Irritable bowel syndrome, anxiety, depression and personality characteristics. Psychiatr Danub 2010, 22:418-424.
57. Addolorato G., Mirijello A., D'Angelo C., Leggio L., Ferrulli A., Abenavoli L., et al. State and trait anxiety and depression in patients affected by gastrointestinal diseases: psychometric evaluation of 1641 patients referred to an internal medicine outpatient setting. Int J Clin Pract 2008, 62:1063-1069.
58. Luo J., Wang T., Liang S., Hu X., Li W., Jin F. Experimental gastritis leads to anxiety- and depression-like behaviors in female but not male rats. Behav Brain Funct 2013, 9:46.
59. Zeng Q., Wang S., Lim G., Yang L., Mao J., Sung B., et al. Exacerbated mechanical allodynia in rats with depression-like behavior. Brain Res 2008, 1200:27-38.
60. Wang S., Tian Y., Song L., Lim G., Tan Y., You Z., et al. Exacerbated mechanical hyperalgesia in rats with genetically predisposed depressive behavior: role of melatonin and NMDA receptors. Pain 2012, 153:2448-2457.
61. Porsolt R.D., Bertin A., Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 1977, 229:327-336.
62. Kelly J.P., Wrynn A.S., Leonard B.E. The olfactory bulbectomized rat as a model of depression: an update. Pharmacol Ther 1997, 74:299-316.
63. Belcheva I., Ivanova M., Tashev R., Belcheva S. Differential involvement of hippocampal vasoactive intestinal peptide in nociception of rats with a model of depression. Peptides 2009, 30:1497-1501.
64. Su Y.L., Wang N., Gao G., Wang J.Y., Luo F. The effect of depression on the thermal nociceptive thresholds in rats with spontaneous pain. Neurosci Bull 2010, 26:429-436.
65. Shi M., Wang J.Y., Luo F. Depression shows divergent effects on evoked and spontaneous pain behaviors in rats. J Pain 2010, 11:219-229.
66. Wang W., Qi W.J., Xu Y., Wang J.Y., Luo F. The differential effects of depression on evoked and spontaneous pain behaviors in olfactory bulbectomized rats. Neurosci Lett 2010, 472:143-147.
67. Shi M., Qi W.J., Gao G., Wang J.Y., Luo F. Increased thermal and mechanical nociceptive thresholds in rats with depressive-like behaviors. Brain Res 2010, 1353:225-233.
68. Burke N.N., Hayes E., Calpin P., Kerr D.M., Moriarty O., Finn D.P., et al. Enhanced nociceptive responding in two rat models of depression is associated with alterations in monoamine levels in discrete brain regions. Neuroscience 2010, 171:1300-1313.
69. Burke N.N., Geoghegan E., Kerr D.M., Moriarty O., Finn D.P., Roche M. Altered neuropathic pain behaviour in a rat model of depression is associated with changes in inflammatory gene expression in the amygdala. Genes Brain Behav 2013, 12:705-713.
70. Zhang M., Dai W., Liang J., Chen X., Hu Y., Chu B., et al. Effects of UCMS-induced depression on nociceptive behaviors induced by electrical stimulation of the dura mater. Neurosci Lett 2013, 551:1-6.
71. Klauenberg S., Maier C., Assion H.J., Hoffmann A., Krumova E.K., Magerl W., et al. Depression and changed pain perception: hints for a central disinhibition mechanism. Pain 2008, 140:332-343.
72. Rhudy J.L., Meagher M.W. Fear and anxiety: divergent effects on human pain thresholds. Pain 2000, 84:65-75.
73. Wang N., Shi M., Wang J.Y., Luo F. Brain-network mechanisms underlying the divergent effects of depression on spontaneous versus evoked pain in rats: a multiple single-unit study. Exp Neurol 2013, 250:165-175.
74. Arora V., Kuhad A., Tiwari V., Chopra K. Curcumin ameliorates reserpine-induced pain-depression dyad: behavioural, biochemical, neurochemical and molecular evidences. Psychoneuroendocrinology 2011, 36:1570-1581.
75. Nagakura Y., Oe T., Aoki T., Matsuoka N. Biogenic amine depletion causes chronic muscular pain and tactile allodynia accompanied by depression: a putative animal model of fibromyalgia. Pain 2009, 146:26-33.
76. Arora V., Chopra K. Possible involvement of oxido-nitrosative stress induced neuro-inflammatory cascade and monoaminergic pathway: underpinning the correlation between nociceptive and depressive behaviour in a rodent model. J Affect Disord 2013, 151:1041-1052.
77. Xu Y., Zhang L., Shao T., Ruan L., Wang L., Sun J., et al. Ferulic acid increases pain threshold and ameliorates depression-like behaviors in reserpine-treated mice: behavioral and neurobiological analyses. Metab Brain Dis 2013, 28:571-583.
78. Krupina N.A., Khlebnikova N.N., Orlova I.N., Grafova V.N., Smirnova V.S., Rodina V.I., et al. Experimental model of combined pain and depression status in rats. Bull Exp Biol Med 2010, 149:479-484.
79. Bravo L., Mico J.A., Rey-Brea R., Perez-Nievas B., Leza J.C., Berrocoso E. Depressive-like states heighten the aversion to painful stimuli in a rat model of comorbid chronic pain and depression. Anesthesiology 2012, 117:613-625.
80. Krishnan V., Han M.H., Graham D.L., Berton O., Renthal W., Russo S.J., et al. Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 2007, 131:391-404.
81. Baumeister A.A., Hawkins M.F., Uzelac S.M. The myth of reserpine-induced depression: role in the historical development of the monoamine hypothesis. J Hist Neurosci 2003, 12:207-220.
82. Simons L.E., Elman I., Borsook D. Psychological processing in chronic pain: a neural systems approach. Neurosci Biobehav Rev 2013.
83. Melzack R., Wall P.D. Pain mechanisms: a new theory. Science 1965, 150:971-979.
84. Kalueff A.V., Ren-Patterson R.F., LaPorte J.L., Murphy D.L. Domain interplay concept in animal models of neuropsychiatric disorders: a new strategy for high-throughput neurophenotyping research. Behav Brain Res 2008, 188:243-249.
85. Kalueff A.V., Stewart A.M. Modeling neuropsychiatric spectra to empower translational biological psychiatry. Behav Brain Res 2014.
86. Nicholas M.K., Coulston C.M., Asghari A., Malhi G.S. Depressive symptoms in patients with chronic pain. Med J Aust 2009, 190:S66-S70.
87. Palermo T.M., Law E., Churchill S.S., Walker A. Longitudinal course and impact of insomnia symptoms in adolescents with and without chronic pain. J Pain 2012, 13:1099-1106.
88. Leys L.J., Chu K.L., Xu J., Pai M., Yang H.S., Robb H.M., et al. Disturbances in slow-wave sleep are induced by models of bilateral inflammation, neuropathic, and postoperative pain, but not osteoarthritic pain in rats. Pain 2013, 154:1092-1102.
89. Lapiz-Bluhm M.D., Bondi C.O., Doyen J., Rodriguez G.A., Bedard-Arana T., Morilak D.A. Behavioural assays to model cognitive and affective dimensions of depression and anxiety in rats. J Neuroendocrinol 2008, 20:1115-1137.